Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.

1999 Preparation
2001 Officially established
2008 It was wholly-owned by Chongqing Zhifei Biological Products Co.,Ltd
2010 Chongqing Zhifei Biological Products Co., Ltd. was listed on GEM of Shenzhen Stock Exchange
2011 Construction of biological products production and R & D center projects.
2013 Changed its name to Anhui Zhifei Longcom Biopharmaceutical Co., LTD.
Granted as a pharmaceutical GMP practice training base
2014 Awarded with the high-tech enterprise certification for the first time
Granted with the title of Anhui Provincial Engineering research Center for Novel Human Vaccine
2016 Granted as an Innovation Base of TB translational Medicine of China National Defense Tuberculosis Association
2018 Its biopharmaceutical Industrial Park (Area A) construction was officially started.
2020 Recombinant Mycobacterium tuberculosis fusion Protein (EC) (trade name: EC-Test ®) was approved for drug registration.